Hyeto Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 06-07-2024
- Paid Up Capital ₹ 1.25 Cr
as on 06-07-2024
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.90 Cr
as on 06-07-2024
- Revenue -8.47%
(FY 2020)
- Profit 139.52%
(FY 2020)
- Ebitda -360.49%
(FY 2020)
- Net Worth 25.41%
(FY 2020)
- Total Assets 23.18%
(FY 2020)
About Hyeto Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.25 Cr.
The company currently has active open charges totaling ₹9.00 M.
Baby Sharma and Ramesh Sharma serve as directors at the Company.
- CIN/LLPIN
U51397JH2006PTC012646
- Company No.
012646
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Nov 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jharkhand
Industry
Company Details
- Location
Ranchi, Jharkhand, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Hyeto Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Baby Sharma  | Director | 27-Nov-2006 | Current |
| Ramesh Sharma | Director | 27-Nov-2006 | Current |
Financial Performance and Corporate Structure Insights of Hyeto Pharmaceuticals.
Hyeto Pharmaceuticals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 8.47% decrease. The company also saw a substantial improvement in profitability, with a 139.52% increase in profit. The company's net worth Soared by an impressive increase of 25.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hyeto Pharmaceuticals?
In 2019, Hyeto Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Harihar Medical Agencies Private Limited
Active 14 years 15 daysBaby Sharma and Ramesh Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 17 Oct 2007 | ₹9.00 M | Open |
How Many Employees Work at Hyeto Pharmaceuticals?
Hyeto Pharmaceuticals has a workforce of 10 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hyeto Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hyeto Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
